Valuation: Terumo Corporation

Market Cap 3,790B 23.84B 20.42B 19.11B 17.49B 32.82B 2,281B 33.26B 226B 88.03B 1,146B 89.51B 87.56B P/E 2027 *
19.8x
P/E 2028 * 19.8x
Enterprise Value 3,844B 24.18B 20.71B 19.38B 17.74B 33.29B 2,314B 33.73B 229B 89.29B 1,162B 90.8B 88.82B EV / Sales 2027 *
3.06x
EV / Sales 2028 * 2.82x
Free-Float
97.07%
Yield 2027 *
1.45%
Yield 2028 * 1.58%
1 day-0.29%
1 week-1.97%
Current month+10.54%
1 month+13.30%
3 months+9.67%
6 months+30.94%
Current year+13.17%
1 week 2,404
Extreme 2404
2,689
1 month 2,133
Extreme 2133
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,746
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 31/03/2022
Director/Board Member 63 20/06/2019
Director/Board Member 75 24/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%-1.97%-7.07%+24.56% 23.94B
+1.91%+4.81%-11.67%+12.26% 198B
+1.13%+2.07%+2.26%+14.15% 118B
+1.05%+1.26%+4.80%+75.58% 60.05B
-1.37%-6.27%+28.79%+60.98% 53.18B
+2.11%+4.25%-2.76%-30.63% 51.11B
+2.35%+2.46%+14.06%-12.16% 34.05B
+4.94%-5.04% - - 28.58B
-0.44%+1.19%+45.73%-9.95% 24.9B
+0.90%+2.10%-3.77%+6.92% 22.98B
Average +1.21%-0.50%+7.82%+15.74% 61.44B
Weighted average by Cap. +1.33%+0.73%+1.71%+17.74%

Financials

2027 *2028 *
Net sales 1,256B 7.9B 6.77B 6.33B 5.8B 10.88B 756B 11.02B 74.8B 29.17B 380B 29.66B 29.02B 1,336B 8.4B 7.2B 6.74B 6.17B 11.57B 804B 11.72B 79.58B 31.03B 404B 31.56B 30.87B
Net income 189B 1.19B 1.02B 952M 871M 1.63B 114B 1.66B 11.24B 4.38B 57.06B 4.46B 4.36B 191B 1.2B 1.03B 964M 882M 1.66B 115B 1.68B 11.39B 4.44B 57.79B 4.52B 4.42B
Net Debt 54.63B 344M 294M 275M 252M 473M 32.88B 479M 3.25B 1.27B 16.52B 1.29B 1.26B -16.66B -105M -89.79M -84.01M -76.9M -144M -10.03B -146M -993M -387M -5.04B -394M -385M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
21/08/26 JP¥2,569.00 -0.29% 4,562,800
20/08/26 JP¥2,576.50 +4.23% 6,932,000
19/08/26 JP¥2,472.00 -4.11% 9,014,900
18/08/26 JP¥2,578.00 -1.60% 5,733,700
17/08/26 JP¥2,620.00 -1.96% 3,448,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,569.00JPY
Average target price
3,133.08JPY
Spread / Average Target
+21.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock